Arkolith/Insider Trading/PMVP/Form 4

Mack David Henry

President and CEO, DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Nov 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2023Gift(G)85K—$0279K
Nov 10, 2023Gift(G)85K—$0165K
Oct 18, 2023Option exercise(M)198K$0.53$105K364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2023Option exercise(M)198K—$0109K

Transaction Codes

G
Gift
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-054997) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML